Long-Term Outcomes With Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials [0.03%]
Mohamed Saad Sayed,Ahmed Farid Gadelmawla,Karim Atta et al.
Mohamed Saad Sayed et al.
Recent randomized controlled trials (RCTs) have reported long-term outcomes comparing biodegradable polymer biolimus-eluting stents (BP-BES) with durable polymer everolimus-eluting stents (DP-EES). This meta-analysis aims to evaluate the lo...
Differential Effects of GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-on Therapy on Outcomes Following Cardiac Surgery: A Propensity Score-Matched Analysis [0.03%]
胰高血糖素样肽-1受体激动剂和钠葡萄糖共转运蛋白-2抑制剂联合治疗对心脏手术后结局的影响：倾向性匹配分析
Shankar Biswas,Ahmed Wahba,Yashasvi Srivastava et al.
Shankar Biswas et al.
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors (SGLT2is) reduce cardiovascular events in nonsurgical populations, yet their comparative effects as combination versus monotherapy...
Dual Antithrombotic Therapy Versus Anticoagulation Alone After Ischemic Stroke in Patients With Atrial Fibrillation and Atherosclerotic Disease: A Meta-Analysis of Efficacy and Safety Outcomes [0.03%]
房颤和动脉粥样硬化性缺血性卒中患者的双联抗栓治疗：有效性和安全性meta分析研究
Zaryab Bacha,Zarar Khan Afridi,Muhammad Mustafa Khan et al.
Zaryab Bacha et al.
Patients with atrial fibrillation and concomitant atherosclerotic disease remain at risk of recurrent ischemic events despite anticoagulation. The benefit of adding antiplatelet therapy to direct oral anticoagulants (DOACs) is still uncerta...
Research Progress on the Regulation of Pulmonary Hypertension by the NOTCH3 Signaling Pathway [0.03%]
NOTCH3信号通路调控肺动脉高压的研究进展
Zhenming Huang,Yi Deng,Jie Zeng et al.
Zhenming Huang et al.
Pulmonary hypertension (PH) has a high lethality rate, severe low age of onset, unclear pathological mechanism, and limited efficacy of existing drugs. The NOTCH3 signaling pathway is an immediate communication that functions through ligand...
Two-Lead Versus Conventional Three-Lead Cardiac Resynchronization Therapy in Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis [0.03%]
射血分数降低的心力衰竭患者接受二导联心脏再同步治疗与传统三导联心脏再同步治疗的有效性比较：系统评价和 meta 分析
Sammy Dawoud,Hany Dawoud,Aakash Hans et al.
Sammy Dawoud et al.
Cardiac resynchronization therapy (CRT) improves outcomes in heart failure (HF) with reduced ejection fraction, but conventional CRT defibrillator (CRT-D) systems require 3 transvenous leads and may increase lead-related complications. Two-...
Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management [0.03%]
系统性硬化症的心肺表现：病理生理、临床表现和治疗管理
Rimsha Ahmad,Juhi Ramchandani,Damien Smith et al.
Rimsha Ahmad et al.
Systemic sclerosis (SSc) is a heterogeneous autoimmune connective tissue disease characterized by immune dysregulation, microvascular dysfunction, and progressive fibrosis. It frequently involves the cardiopulmonary system, resulting in man...
Antonis A Manolis,Theodora A Manolis,Apostolos Vouliotis et al.
Antonis A Manolis et al.
Ranolazine is a drug with a dual mode of action as a metabolic modulator and membrane stabilizer. It is better known for its anti-ischemic and antianginal properties rather than its antiarrhythmic effects. It also possesses favorable antiox...
Cardiac Autonomic Dysfunction and Sudden Cardiac Death in Amyotrophic Lateral Sclerosis: Clinical Implications and Considerations for Care [0.03%]
肌萎缩侧索硬化的心脏自主神经功能障碍和突发性心脏死亡：临床意义及护理考量
Kelly Fisher,Alexandra Ligay,Michelle Stratford et al.
Kelly Fisher et al.
Amyotrophic lateral sclerosis (ALS) is traditionally viewed as a motor neuron disease that progresses from muscular weakness to respiratory failure and death. Increasing evidence, however, demonstrates clinically meaningful involvement of t...
StrokeNet Thrombectomy Endovascular Platform (STEP): A Catalyst for Stroke Research: Retraction [0.03%]
StrokeNet血栓切除血管内平台（STEP）：推动卒中研究的催化剂：撤稿通知
Chaitanya B Medicherla,Amr Salem,Vikalpa Dammavalam et al.
Chaitanya B Medicherla et al.